Amwell reported a total of $245.3 million in revenue during its first year on the market during its Q4 earnings call. This number represents a 65% revenue increase YoY.
The Boston-based company finished off Q4 by beating its financial expectations. It's no secret the telehealth giant has seen a bump in telehealth usage as a result of the COVID-19 pandemic.
"The pandemic, while terrible, only...
Shares of consumer-friendly telehealth and wellness company Hims & Hers took a hit late last week when the company pulled back the curtain on its first quarterly earnings since going public through a special purpose acquisition company (SPAC) merger.
While the company posted 2020 revenue that beat market expectations, its roughly $16 trading price immediately dipped from about $16 to the $14...
Teladoc Health has capped off what has proven to be a defining year for the virtual care company, if not telehealth at large.
In its quarterly earnings call yesterday afternoon, the company announced that it had outpaced its revenue and earnings targets for both Q4 and FY 2020. In addition, CEO Jason Gorevic highlighted investments and acquisitions made throughout the year to develop services...
Despite the challenges of 2020, Dexcom was able to close the year out with financial growth for both the fourth quarter and the full year, according to its earnings report released Thursday.
In the earnings call, Dexcom’s chairman, president and CEO Kevin Sayer voiced his gratitude to the company for surpassing its goals even under the extreme circumstances last year.
“In any given year, these...
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
Despite having some uncertainty in the impacts of the COVID-19 pandemic, Dexcom was able to produce significant year-over-year growth in Q2 2020.
Sayer attributes much of the growth to a steady increase in knowledge...
Teladoc Health continues its strong upward trend during its second fiscal quarter, with CEO Jason Gorevic informing investors yesterday that the company had outperformed "all key financial and operation metrics."
Similar to the first quarter, the telehealth company is touting massive year-over-year (YoY) growth in revenue, visit volume and new registrations, as well as the acquisition of several...
One Medical, the tech enabled health startup that made headlines when it went public in January, is reporting a 25% year-over-year revenue growth. However, it still came up short of meeting earnings per share expectations.
The company, officially named 1Life Healthcare, uses a hybrid model, its members have access to 24-7 virtual health-services as well as the ability to visit brick-and-mortar...
This quarter Dexcom raked in $405 million in revenue, compared to $280.5 million in 2019’s Q1. This represents a 44% increase year over year (YoY), and beats the company's revenue goal by $46.7 million. Dexcom attributes its success to its growing user rate.
The gross profits from Q1 were $258.7 million. However, operating expenses have increased, coming in at $215.4 million in 2020 Q1, versus $...
It was another strong quarter for the ever-growing Livongo Health, which yesterday reported to investors a 137% rise in year-over-year Q4 revenue from $21.2 million to $50.2 million. Full-year revenues followed a similar path, growing 149% from $68.4 million in 2018 to $169.9 million in 2019.
“Livongo finished the year with excellent momentum, exceeding all of our guidance metrics, achieving...
The year 2019 was good to Teladoc Health. Although still operating at a loss, the virtual care provider enters the new year hot with reports that revenue and visits — domestic and international, paid membership and visit fee — all outpaced the company’s projections.
Teladoc said during a Wednesday afternoon earnings call that it is expecting that growth to continue. Part of this is due to the...
